<DOC>
	<DOCNO>NCT02167594</DOCNO>
	<brief_summary>This study evaluate 18F-AV-1451 brain image tau subject progressive supranuclear palsy ( PSP ) , corticobasal degeneration ( CBD ) healthy volunteer .</brief_summary>
	<brief_title>Tau Imaging Subjects With Progressive Supranuclear Palsy , Corticobasal Degeneration Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Supranuclear Palsy , Progressive</mesh_term>
	<criteria>Cognitively Healthy Volunteers Minimental state examination ( MMSE ) ≥ 28 No history cognitive decline parkinsonian motor disorder CBD PSP subject Able walk 10 step minimal assistance MMSE ≥ 14 ≤ 30 Subject reliable study partner agree accompany subject visit spend least 5 hour per week subject PSP subject Meet National Institute Neurological Disorders Stroke Society Progressive Supranuclear Palsy ( NINDSSPSP ) probable possible PSP criterion modify Neuroprotection Natural History Parkinson Plus Syndromes ( NNIPPS ) clinical trial CBD subject Meets 2013 consensus criterion possible probably corticobasal degeneration , corticobasal syndrome ( CBS ) subtype All subject Have evidence structural abnormality vascular disease , large stroke severe white matter disease mass lesion screen MRI Claustrophobia Current clinically significant cardiovascular disease clinically significant abnormality screen ECG ( e.g . QTC &gt; 450 msec ) Have history risk factor Torsades de Pointes ( e.g . heart failure , hypokalemia , family history long QT syndrome ) Have current clinically significant infectious disease , endocrine metabolic disease , pulmonary , renal hepatic impairment , cancer Females childbearing potential surgically sterile , refrain sexual activity use reliable method contraception Have receive participated trial investigational medication past 30 day Have nonstudy related radiopharmaceutical imaging treatment procedure within 7 day prior study image session Have history neuroleptic use prolong period time within past 6 month PSP CBD subject Have evidence amyloid deposition Meet National Institute AgingAlzheimer 's Association criterion probable Alzheimer 's Disease Have neurological condition CBS PSP could account cognitive motor deficit Serum plasma progranulin level less one standard deviation normal subject mean laboratory perform assay Have highrsk family history suggestive TDP43 pathology know mutation</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>